Object. The management of parasagittal and falcine meningiomas centers around the relationship between the tumor and the venous anatomy of the superior sagittal sinus (SSS) and the bridging veins. The present study aims to address surgical outcomes in a focused cohort of these patients for which there is not clinical equipoise between radiosurgery and transcranial resection.
A s the second most common region of origin for intracranial meningiomas, the basic pathological, anatomical, and surgical features of parasagittal and falcine meningiomas are familiar to most neurosurgeons. [3] [4] [5] [11] [12] [13] More specifically, the management of these tumors centers around the relationship between the tumor and venous anatomy of the SSS, and the large cerebral veins that enter the sinus in the proximity of these tumors. 3, 8, 12, 16, 18 The propensity for these tumors to invade the venous sinus, or to encase or adhere to cerebral veins, can greatly complicate efforts to achieve the safe, complete removal of the tumor and its involved dural base. 3, 8, 12, 16, 18 Over recent decades, SRS and 3D-CRT have been established as safe and effective methods for limiting the growth of appropriately sized meningiomas. 9, 10 Due to the lack of any markedly radiosensitive structures in the vicinity of these parasagittal and interhemispheric tumors, some investigators have proposed the use of radiosurgery as the sole treatment for most small parasagittal and falcine meningiomas. 8 In cases with clinical equipoise, specifically cases of small, minimally symptomatic tumors without imaging features that are of concern or a known history of rapid growth on serial imaging studies, we agree that SRS or 3D-CRT should be given serious consideration, and these are commonly offered as firstline therapy for these patients at our institution.
Abbreviations used in this paper: CRT = conformal radiotherapy; EGFR = epidermal growth factor receptor; GTR = gross-total resection; SRS = stereotactic radiosurgery; SSS = superior sagittal sinus; STR = subtotal resection.
In the present study our aim was to address surgical outcomes in a focused cohort of patients with parasagittal and falcine meningiomas for which there is not clinical equipoise between SRS and transcranial resection. 8 Generally, these are large tumors, ones with rapid serial growth, tumors with imaging features that are of concern, or tumors with significant symptoms prompting the patient to decide on surgical removal. 8 Older surgical series usually include patients from the era before radiosurgery in part or in full, and generally have not focused on these patients, who are the ones we currently treat with surgical removal, and for whom outcomes data for surgery are most relevant to present neurosurgical practice.
Methods

Patient Population and Outcome Assessment
These patients were adults (age ≥ 18 years) who underwent surgery at the University of California San Francisco between 1991 and 2007, had preoperative and postoperative (< 72 hours) MR imaging, and had at least 1 year of clinical follow-up. Patients with hemangiopericytomas were excluded from the study. The MR imaging studies were reviewed for each patient to confirm the diagnosis of a parasagittal or falcine meningioma, which were defined as those that primarily arose either from the falx or from the dura mater at the lateral edge of the SSS. Patients were included in this analysis only if radiosurgery did not seem to be an appropriate alternative treatment option, given the clinical and radiographic characteristics of the specific cases. In general, these cases involved tumors greater than 2.5 cm in largest diameter, tumors with imaging features raising concerns for higher histological grade (that is, irregular borders, an indistinct interface with the cortical surface), tumors growing rapidly on serial imaging, and tumors with significant symptoms referable to mass effect.
Central pathological review was performed on the basis of the WHO guidelines. 7 Clinical data were collected from patient records and telephone interviews. All clinical assessments were performed by a neurosurgeon. In each case, the extent of resection and Simpson grade 6, 15 were determined using a combination of the surgeon's assessment and MR imaging. This study was approved by our institution's committee on human research.
Microsurgical Technique, Surgical Strategy, and Perioperative Management
Intraoperative neuronavigation was routinely used to minimize the skin incision and craniotomy size while attempting a Simpson Grade 1 resection. Preoperative embolization was considered for all large tumors, although often the vascular supply for these larger tumors included pial supply. In general, en bloc resection was not attempted due to tumor size, and instead the tumor was debulked from within by using a Cavitron ultrasonic aspirator (Valleylab) or, more recently, a Sonopet ultrasonic aspirator (Miwatec). Careful attention was paid to identifying and respecting the arachnoid plane at the tumor-brain interface, which facilitates complete resection and minimizes pial vessel injury. Whenever possible, involved dura was resected with a 2-cm circumferential margin, and the dura was closed with either a pericranial graft or the artificial dural substitute. For lesions with bone invasion, the craniectomy site was repaired using a combination of titanium mesh and methylmethacrylate. This composite cranioplasty technique was used because the craniectomy defects tended to be large, and the resultant construct provided strength in compression and tension.
Although the goal of the operation from the outset was total tumor removal, the discovery of significant involvement of the SSS or the bridging cortical veins often limited these attempts, and was managed as follows. We generally do not resect patent cortical bridging veins involved with tumor, and will leave tumor remnants that are densely adherent to these vessels. Completely occluded venous sinuses were resected, taking care to spare any patent cortical bridging veins on the edges of the occluded portion of the sinus. Complete sinus occlusion was generally confirmed using the venous phases obtained during the digital subtraction angiography studies used for endovascular tumor embolization; however, if embolization was not performed, a technically adequate MR venogram was used as evidence of complete sinus occlusion. Doppler ultrasonography was used intraoperatively for further confirmation of the lack of flow across the affected sinus, and in combination with information from displayed image sets on navigation systems (2D T1-weighted post-Gd MR imaging studies and 3D MR venography). More commonly, we noted invasion of tumor into a patent sinus. In many cases, we have found that a small invasion of the SSS can be removed using patient microsurgical dissection of the dural layers, with hemostasis obtained with bipolar coagulation, hemostatic agents, and fibrin glues when necessary, avoiding the need for patch grafting, venous-venous bypass, or other reconstruction techniques to repair the sinus. We do not attempt removal of larger degrees of tumor invasion of a patent sinus, and instead leave this portion of the tumor, which is observed using serial imaging, and treated with radiosurgery at the time of progression, or immediately postoperatively. For falcine meningiomas, that portion of the falx below the SSS is resected after the bulky tumor is removed. This then qualifies the removal as Simpson Grade 1.
Intraoperatively, all patients received decadron (10 mg), mannitol (1 g/kg), and ceftriaxone (1 or 2 g) at the time of incision. Postoperatively, all patients were cared for in a neurointensive care unit for 1 day before returning to the ward. On postoperative Day 2, a prophylactic dose of enoxaparin (40 mg subcutaneously each day) was initiated in all patients and continued for 1 week. Routine use of venous thrombosis prophylaxis was not started until after 2001. 1 The incidence of postoperative intracranial hemorrhage was no different in the patient groups before or after prophylaxis was begun.
2 Irrespective of preoperative seizure history, all patients had also received loading doses of an antiepileptic agent at the time of surgery (Dilantin initially, Keppra more recently), which was continued for 1 week postoperatively and then discontinued.
In addition to immediate postoperative imaging, MR imaging was performed at 1-year intervals for patients with known residual tumor after surgery, and those with WHO Grade II or III tumors. Patients with gross totally resected WHO Grade I tumors were followed clinically, with repeat imaging performed if recurrence was suggested by the development of new or worsened symptoms. Recurrence was defined as any unequivocal, new enhancement in the resection cavity. Tumor progression was defined as any unequivocal increase in the size of the residual tumor seen on the immediate postoperative imaging. For purposes of comparing rates of tumor control, recurrence and progression were treated as a similar event.
Statistical Analysis
Survival analysis was performed using the KaplanMeier method. Binary variables were compared using the Pearson chi-square test. Continuous variables were compared using an independent samples t-test or ANOVA, after statistical confirmation of data normality. Continuous variables are presented as the mean ± SE. Statistical tests were considered significant when p was < 0.05 after correcting for multiple comparisons by using the Bonferroni method. All odds ratios reflect the risk of having new or worse neurological dysfunction after surgery.
Results
Patient and Tumor Demographics
We identified 135 patients with large, symptomatic, and/or growing parasagittal/falcine meningiomas who underwent surgical removal of their lesion at our institution between 1991 and 2007. The median length of follow-up was 7.6 years (range 1.7-18.6 years). The basic demographic characteristics are summarized in Table 1 . Of particular note, significant invasion of the SSS was noted in 61 (45%) of 135 cases. The age and sex distribution of these patients did not differ significantly from that in patients without sinus invasion. Rates of cystic degeneration did not differ between these groups (33% vs 21%, not significant). Not surprisingly, tumors invading the sinus were more commonly WHO Grade II or III (57% vs 34%, p < 0.01), and were larger (56 ± 9.2 cm 3 vs 34 ± 3.6 cm 3 ; p < 0.01) than tumors that did not invade the sinus. There was no difference in mean tumor volume between tumors associated with the anterior, middle, and posterior thirds of the sinus (38 ± 8 cm 3 vs 37 ± 4.3 cm 3 vs 43 ± 3.6 cm 3 ; not significant, based on ANOVA testing) (see Table 2 ).
Frequency of Presenting Symptoms
The presenting symptoms for patients in this series are summarized in Table 3 . Approximately one-fourth of all patients, many of whom had tumors more than 5 cm in largest diameter, presented without referable symptoms or deficits (35 of 135). Headaches (in 24 of 135) and seizures (also in 24 of 135) occurred commonly. Interestingly, hemiparesis and unilateral upper-extremity and/or facial weakness occurred as frequently as lower-extremity weakness. Also notable was the interesting occurrence of new-onset psychotic symptoms in 5 patients, 4 of whom demonstrated invasion of the SSS. Figure 1 summarizes the management approach we used in the 61 patients with evidence of SSS invasion at surgery, and in the 74 patients without sinus invasion, and the extent of resection we obtained in these patients. Six of 61 patients with sinus occlusion were found to have complete sinus occlusion on preoperative studies, and the involved portion of the sinus was fully resected in 5 of these 6 patients, with the remaining patient undergoing STR and immediate radiosurgery, leaving the involved sinus unresected due to the difficulty in separating the involved segment and the tumor from large, patent bridging cortical veins. None of these patients experienced recurrence or progression of their tumor over a median followup period of 11.6 years (range 2.86-13.9 years).
Management of SSS Invasion and the Impact on Tumor Control
In the remaining 55 patients with patent sinuses, we noted that in 33 of 55 cases the sinus invasion was minor, and could be removed using careful microsurgical dissection, with hemostasis obtained using Gelfoam, fibrin glue, and occasionally 1-2 Weck clips. In the other 22 cases, more significant sinus invasion was noted, and the tumor was subtotally resected, the exposed attachments coagulated, and the remnant tumor left in the sinus. Eight of 22 patients undergoing STR received SRS within 3 months after surgery to treat the residual tumor in the sinus. None of the patients who received upfront radiosurgery demonstrated any evidence of subsequent tumor growth during follow-up. Of the remaining patients, 1 of 33 receiving complete tumor removal, and 2 of 14 receiving STR experienced tumor recurrence or progression over a follow-up period of 7.6 years (range 1.7-18.6 years). All 3 patients with recurrence had WHO Grade II or III tumors, which were treated with repeat surgery at the time of recurrence. Of the 74 cases in which no sinus invasion was found at surgery, GTR was obtained in 71 of them. In the cases in which STR was performed, the tumor was adherent to bridging cortical veins, which forced an STR to spare the venous anatomy. Two of 3 patients undergoing STR underwent radiosurgery within 3 months of surgery, and the third patient demonstrated tumor growth on follow-up imaging at 58 months, at which point SRS was performed, which achieved tumor growth arrest. There were 5 recurrences in the patients who underwent GTR, 3 of which involved WHO II or III tumors, which recurred at 1.58, 2.16, and 7.58 years postoperatively, and were treated with repeat surgery at the time of recurrence. The other 2 patients had WHO Grade I tumors, which recurred at 3.87 and 5.78 years postoperatively, and these individuals underwent radiosurgery at the time of recurrence, without further evidence of tumor growth.
We performed Kaplan-Meier analysis for patients with WHO Grade I tumors to compare recurrence/progression-free survival for patients who underwent GTR versus STR. Patients who underwent upfront radiosurgery to the remnant lesion following STR were excluded from this analysis, to study the natural history of small tumor remnants that remained in the SSS or were attached to Fig. 1 . Postoperative tumor control after surgery for parasagittal and falcine meningiomas; a graphic depiction of the frequency of sinus invasion and sinus occlusion in our patients, and the methods by which their disease was managed. Rates of recurrence for each group are noted. the veins. As seen in Fig. 2 , there was no difference in rates of tumor control for patients who received STR for a WHO Grade I tumor, followed by close observation, compared with those undergoing GTR, primarily because we did not observe any cases in which the tumor remnant in the SSS demonstrated interval growth on serial imaging studies.
Morbidity After Surgical Removal of Parasagittal/Falcine Meningiomas
In this series, 81% of patients did not experience any complications as a result of surgery (Table 4) . Four of 135 patients experienced new or worsened neurological deficits after surgery, largely referable to surgical manipulation around the motor strip. Medical complications were relatively uncommon (10 of 135 patients), and many were specific to neurosurgical procedures (seizures, serious hyponatremia).
Neurosurgical complications constituted the majority of complications in this series (16 of 135). Wound complications were the most common. Four patients required a CSF diversion procedure related to new postoperative hydrocephalus. There was 1 episode of venous infarction noted. The cause of venous infarction in this case was not determined; however, it did not occur in a patient with a known vein sacrifice, or with documented venous sinus thrombosis. Two patients required a return to the operating room to evacuate a subdural hematoma. One of these occurred in the setting of idiopathic thrombocytopenia, which developed in an inpatient. One case had to be aborted due to the development of an intraoperative air embolus during manipulation of the SSS. This patient underwent a successful repeat attempt at tumor resection at a later date. One patient developed significant postoperative edema requiring temporary removal of the bone flap. Based on postoperative imaging, this did not appear to be due to venous infarction.
Discussion
In this study, we report our experience with surgical removal of parasagittal and falcine meningiomas in a focused cohort of patients, who we believe best represent the types of patients treated with resection in contemporary neurosurgery (namely, those with meningiomas without clinical equipoise who undergo less invasive treatments, such as stereotactic radiosurgery, 3D-CRT, or observation). These tumors are frequently higher grade, often symptomatic, and in many cases are massive. More than one-third of the tumors in this series exceeded 5 cm in diameter, and 8 tumors in this series exceeded 8 cm in diameter. Despite these challenges, we have found that good tumor control with acceptable rates of morbidity can be achieved with careful microsurgical technique, and with thoughtful consideration of the venous anatomy and its relationship to the tumor.
In addition to presenting surgical outcomes for patients with these tumors, a principal goal of our analysis was to provide data regarding the surgical and clinical significance of invasion of the SSS. Whereas tumors causing complete sinus occlusion can usually be removed in their entirety, and tumors that do not invade the sinus can usually be resected without great difficulty, the management of tumors invading the SSS and causing incomplete sinus occlusion have always posed the greatest surgical dilemma. [3] [4] [5] 14 As microneurosurgical techniques evolved, an emphasis on increasingly aggressive attempts at com- plete surgical removal of parasagittal meningiomas similarly evolved. 12, [16] [17] [18] [19] [20] In this treatment paradigm, complete resection is the goal of all surgeries, with direct surgical removal of tumor from the sinus performed if necessary. Maintenance of central venous outflow in this approach is achieved using surgical patching of the sinus, or a bypass procedure if necessary.
This study presents our results with the alternate approach of removing as much tumor as possible while preserving major cortical veins, and leaving tumor remnants that significantly involve the sinus. 8 In this approach, the residual tumor can be followed closely with serial imaging, and treated with radiosurgery in the event of subsequent growth. We suspect that this is the approach used by a growing number of neurosurgical centers presently. In most cases, we have found that even with minor degrees of sinus invasion, we were able to remove all of the tumor without heroic efforts. Either way, the tumor control rates we have observed are excellent, with the majority of the recurrences that we observed resulting from higher-grade tumor histopathological features. These data suggest that small residual portions of WHO Grade I tumors left in and around the SSS generally do not grow appreciably for several years after surgery, even without adjuvant radiation-based treatments.
The results do not obviate the need for many years of close imaging follow-up, but they suggest that radiosurgical management of residual disease might be delayed or even avoided in some patients. We think that in general these data support a gradual move toward less aggressive resection in cases of tumor invasion of a patent sinus. In cases of minor invasion, we will continue to attempt to address these fragments surgically; however, given our good results by simply leaving tumor in the sinus, following the remnant with serial imaging, and managing recurrences with radiosurgery, it seems less necessary to be surgically heroic in these cases. For example, in cases involving the anterior one-third of the SSS in which the MR venogram shows at least 2 other draining veins on the opposite side, remote from the region of involved sinus, we believe it is safe to consider limited sinus resection. In cases of complete occlusion of the SSS, total excision is safe. In cases with incomplete occlusion, or when there are fewer than 2 veins on the opposite side, separation of the leaves of the dura mater preserving the inner layer of the lateral wall of the SSS is acceptable. Clipping or preferably suturing an opened lateral wall of sinus can be done. In fact, one option is to use tandem clips parallel to the axis of the sinus, suture behind the clips, and then remove the clips, which reduces artifacts for follow-up imaging.
More notably, close observation and radiosurgery as needed are important in the management of WHO Grade I tumors that invade a patent sinus, especially for remnants in the middle and posterior one-third of the sinus. Our data suggest that in many cases radiosurgery can be delayed, because many tumor remnants in the sinus do not grow on serial imaging. We do not think there is a role for planned resection and grafting of the sinus, given the great rates of tumor control seen with radiosurgery. We treat WHO Grade II tumors with selective use of radiotherapy. More specifically, based on our previously published data linking the absence of EGFR staining with poor outcome, 21 we use radiotherapy to treat all subtotally resected and all gross totally resected tumors that are EGFR negative, or have elevated MIB-1 labeling (> 10%), whereas we observe patients with WHO Grade II tumors that have positive wild-type EGFR staining, MIB-1 labeling < 10%, and in which the patient has received a GTR. We treat all WHO Grade III tumors with external-beam radiotherapy.
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Conclusions
We present our experience with surgical management of medium-to-large meningiomas arising from the parasagittal dura mater and/or the falx cerebri. Importantly, these data provide a more modern estimate of the expected outcomes that can be obtained after treating patients with these tumors, by using a combination of image guidance, advanced microsurgical tools, and treatments with CRT. 
